资讯
Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease ...
A witness shouted at the men that the victim was undergoing treatment for leukaemia, Grimsby Crown Court heard ...
2 天
Wirral Globe on MSNClatterbridge Cancer Centre signs up first UK patient for trialA cancer research centre is leading the way in a new trial aiming to improve treatment for prostate cancer patients.
When men isolate, it affects not only themselves ... In either case, this means cancer patients have to be extra cautious in these times. “Our lead admin, Joe Bullock, saw that more guys were ...
The new surgical method, called NeuroSAFE, preserves the nerves that run through the prostate’s outer layers, which are thought to be responsible for producing erections, according to a report ...
7 天on MSN
Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have validated a test that can accurately predict which ...
FX's Dying for Sex is inspired by a real terminal cancer patient who began a journey of sexual exploration when she got her ...
Bert Scholl was just a few weeks from his 37th birthday when he got the diagnosis few people his age expect – colorectal ...
11 天
Onlymyhealth on MSNWhy PSA Levels Increase After Prostate Cancer TreatmentElevated PSA levels can signal both malignant and benign prostate cancer But what does it mean if the PSA levels rise after a ...
13 天
News Medical on MSNWorld first as MHRA approves trofolastat for diagnostic imaging of prostate cancer in menThe Medicines and Healthcare products Regulatory Agency (MHRA) has approved trofolastat (RoTecPSMA), the first prostate-specific membrane antigen (PSMA)-targeting product authorised for use with ...
The Medicines and Healthcare products Regulatory Agency (MHRA) in the UK said it has given a world-first approval to Rotop's ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果